$5.44
-0.08-1.45%
al cierre: -
$5.40
-0.04-0.74%
After hour: 7:59 PM EDT
Comments
Loading...
Recursion Pharmaceuticals Informe de interés a corto plazo
RXRXNASDAQ
Informe de interés en corto
El interés corto en Recursion Pharmaceuticals Inc (NASDAQ:RXRX) ha disminuido durante el último período de informe, aumentando en descenso desde 133.41M hasta 126.35M. Esto representa el 31.05% de las acciones disponibles públicamente de la empresa.
El interés en corto en Recursion Pharmaceuticals Corp (XNAS:RXRX) disminuyó durante el último período de informe, cayendo de 280,30 millones a 275,20 millones. Esto hizo que el 1,17 % de las acciones disponibles públicamente de la empresa se pusieran en corto.
Basado en el volumen promedio reciente de 69.40M acciones negociadas por día, tomaría 1.82 día(s) para que los poseedores de este interés corto cierren sus posiciones sin impulsar bruscamente el precio de las acciones.
Interés en corto
126.35M
Interés en corto %
31.1%
Días para cubrir
1.82
Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|
RXRX | Recursion Pharmaceuticals, Inc | 10/15/2025 | 10/24/2025 | 31.05% | 406,854,783 | 126,348,417 | 69,403,970 | 1.82 | |
RXRX | Recursion Pharmaceuticals, Inc | 09/30/2025 | 10/09/2025 | 32.79% | 406,854,783 | 133,407,394 | 35,928,102 | 3.71 | |
RXRX | Recursion Pharmaceuticals, Inc | 09/15/2025 | 09/24/2025 | 32.45% | 406,854,783 | 132,044,177 | 16,730,338 | 7.89 | |
RXRX | Recursion Pharmaceuticals, Inc | 08/29/2025 | 09/10/2025 | 30.50% | 406,854,783 | 124,079,106 | 16,288,078 | 7.62 | |
RXRX | Recursion Pharmaceuticals, Inc | 08/15/2025 | 08/26/2025 | 30.26% | 403,883,402 | 122,223,405 | 18,598,548 | 6.57 | |
RXRX | Recursion Pharmaceuticals, Inc | 07/31/2025 | 08/11/2025 | 29.10% | 403,883,402 | 117,535,748 | 33,007,194 | 3.56 | |
RXRX | Recursion Pharmaceuticals, Inc | 07/15/2025 | 07/24/2025 | 28.60% | 403,883,402 | 115,527,481 | 30,617,579 | 3.77 | |
RXRX | Recursion Pharmaceuticals, Inc | 06/30/2025 | 07/10/2025 | 29.07% | 403,883,402 | 117,408,745 | 27,422,295 | 4.28 | |
RXRX | Recursion Pharmaceuticals, Inc | 06/13/2025 | 06/25/2025 | 31.87% | 376,801,373 | 120,075,634 | 36,749,679 | 3.27 | |
RXRX | Recursion Pharmaceuticals, Inc | 05/30/2025 | 06/10/2025 | 28.94% | 376,801,373 | 109,034,492 | 19,542,619 | 5.58 | |
RXRX | Recursion Pharmaceuticals, Inc | 05/15/2025 | 05/27/2025 | 27.66% | 376,801,373 | 104,219,046 | 22,023,595 | 4.73 | |
RXRX | Recursion Pharmaceuticals, Inc | 04/30/2025 | 05/09/2025 | 24.71% | 376,801,373 | 93,117,686 | 14,415,360 | 6.46 | |
RXRX | Recursion Pharmaceuticals, Inc | 04/15/2025 | 04/25/2025 | 25.57% | 369,684,676 | 94,515,655 | 30,201,892 | 3.13 | |
RXRX | Recursion Pharmaceuticals, Inc | 03/31/2025 | 04/09/2025 | 23.94% | 369,684,676 | 88,501,554 | 15,553,625 | 5.69 | |
RXRX | Recursion Pharmaceuticals, Inc | 03/14/2025 | 03/25/2025 | 23.38% | 369,684,676 | 86,416,564 | 20,466,609 | 4.22 | |
RXRX | Recursion Pharmaceuticals, Inc | 02/28/2025 | 03/11/2025 | 21.83% | 369,684,676 | 80,716,710 | 37,222,808 | 2.17 | |
RXRX | Recursion Pharmaceuticals, Inc | 02/14/2025 | 02/26/2025 | 21.06% | 358,336,087 | 75,450,107 | 33,427,821 | 2.26 | |
RXRX | Recursion Pharmaceuticals, Inc | 01/31/2025 | 02/11/2025 | 17.79% | 358,336,087 | 63,748,978 | 17,727,159 | 3.6 | |
RXRX | Recursion Pharmaceuticals, Inc | 01/15/2025 | 01/27/2025 | 18.94% | 358,336,087 | 67,857,806 | 15,986,169 | 4.24 | |
RXRX | Recursion Pharmaceuticals, Inc | 12/31/2024 | 01/10/2025 | 20.68% | 356,513,648 | 73,735,739 | 16,275,526 | 4.53 | |
RXRX | Recursion Pharmaceuticals, Inc | 12/13/2024 | 12/24/2024 | 18.82% | 356,513,648 | 67,097,533 | 17,100,772 | 3.92 | |
RXRX | Recursion Pharmaceuticals, Inc | 11/29/2024 | 12/10/2024 | 19.03% | 356,513,648 | 67,845,763 | 12,760,225 | 5.32 | |
RXRX | Recursion Pharmaceuticals, Inc | 11/15/2024 | 11/26/2024 | 18.12% | 356,353,259 | 64,573,303 | 6,991,077 | 9.24 | |
RXRX | Recursion Pharmaceuticals, Inc | 10/31/2024 | 11/11/2024 | 24.56% | 254,214,840 | 62,427,631 | 3,799,526 | 16.43 | |
RXRX | Recursion Pharmaceuticals, Inc | 10/15/2024 | 10/24/2024 | 22.97% | 258,803,877 | 59,436,441 | 4,461,852 | 13.32 | |
RXRX | Recursion Pharmaceuticals, Inc | 09/30/2024 | 10/09/2024 | 30.91% | 202,439,295 | 62,578,756 | 5,425,024 | 11.54 | |
RXRX | Recursion Pharmaceuticals, Inc | 09/13/2024 | 09/24/2024 | 29.22% | 202,439,295 | 59,162,424 | 4,852,523 | 12.19 | |
RXRX | Recursion Pharmaceuticals, Inc | 08/30/2024 | 09/11/2024 | 27.68% | 202,439,295 | 56,030,343 | 4,357,903 | 12.86 | |
RXRX | Recursion Pharmaceuticals, Inc | 07/31/2024 | 08/09/2024 | 24.88% | 202,439,295 | 50,366,647 | 3,844,470 | 13.1 | |
RXRX | Recursion Pharmaceuticals, Inc | 07/15/2024 | 07/24/2024 | 26.18% | 188,412,721 | 49,327,170 | 5,762,041 | 8.56 | |
RXRX | Recursion Pharmaceuticals, Inc | 06/28/2024 | 07/10/2024 | 23.84% | 188,412,721 | 44,919,972 | 9,626,203 | 4.67 | |
RXRX | Recursion Pharmaceuticals, Inc | 06/14/2024 | 06/26/2024 | 28.50% | 157,643,491 | 44,931,836 | 3,773,645 | 11.91 | |
RXRX | Recursion Pharmaceuticals, Inc | 05/31/2024 | 06/11/2024 | 27.68% | 157,643,491 | 43,637,834 | 4,499,180 | 9.7 | |
RXRX | Recursion Pharmaceuticals, Inc | 05/15/2024 | 05/24/2024 | 26.88% | 157,643,491 | 42,368,012 | 5,893,334 | 7.19 | |
RXRX | Recursion Pharmaceuticals, Inc | 04/30/2024 | 05/09/2024 | 25.69% | 157,643,491 | 40,497,913 | 4,247,037 | 9.54 | |
RXRX | Recursion Pharmaceuticals, Inc | 04/15/2024 | 04/24/2024 | 24.58% | 157,477,026 | 38,704,268 | 4,392,347 | 8.81 | |
RXRX | Recursion Pharmaceuticals, Inc | 03/28/2024 | 04/09/2024 | 25.44% | 156,275,453 | 39,761,938 | 5,885,026 | 6.76 | |
RXRX | Recursion Pharmaceuticals, Inc | 03/15/2024 | 03/26/2024 | 27.85% | 156,275,453 | 43,520,191 | 7,080,455 | 6.15 | |
RXRX | Recursion Pharmaceuticals, Inc | 02/29/2024 | 03/11/2024 | 27.40% | 156,275,453 | 42,815,751 | 11,571,921 | 3.7 | |
RXRX | Recursion Pharmaceuticals, Inc | 02/15/2024 | 02/27/2024 | 27.83% | 137,415,977 | 38,240,528 | 5,530,719 | 6.91 | |
RXRX | Recursion Pharmaceuticals, Inc | 01/31/2024 | 02/09/2024 | 27.85% | 137,415,977 | 38,272,534 | 4,993,651 | 7.66 | |
RXRX | Recursion Pharmaceuticals, Inc | 01/12/2024 | 01/24/2024 | 27.72% | 137,415,977 | 38,088,079 | 8,653,427 | 4.4 | |
RXRX | Recursion Pharmaceuticals, Inc | 12/29/2023 | 01/10/2024 | 26.95% | 137,415,977 | 37,036,264 | 4,553,307 | 8.13 | |
RXRX | Recursion Pharmaceuticals, Inc | 12/15/2023 | 12/27/2023 | 26.94% | 137,415,977 | 37,016,053 | 5,263,124 | 7.03 | |
RXRX | Recursion Pharmaceuticals, Inc | 11/30/2023 | 12/11/2023 | 26.14% | 137,415,977 | 35,921,010 | 4,598,000 | 7.81 | |
RXRX | Recursion Pharmaceuticals, Inc | 11/15/2023 | 11/27/2023 | 25.83% | 137,415,977 | 35,495,991 | 5,290,105 | 6.71 | |
RXRX | Recursion Pharmaceuticals, Inc | 10/31/2023 | 11/09/2023 | 24.05% | 137,415,977 | 33,049,509 | 2,410,830 | 13.71 |
En busca de los valores más cortos?